AOS13 Denosumab versus zoledronic acid for the prevention...

AOS13 Denosumab versus zoledronic acid for the prevention of skeletal-related events in patients with bone metastases secondary to solid tumours: An integrated analysis of three phase 3 studies

A.T. Stopeck, G. Richardson, S. Siena, A. Lipton, J. Brown, K. Fizazi, D. Henry, F. Saad, C. Ke, A. Braun
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
48
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.ejca.2012.02.030
File:
PDF, 41 KB
english, 2012
Conversion to is in progress
Conversion to is failed